- Home
- ABEO vs KTF Comparison
ABEO vs KTF Comparison
Compare ABEO & KTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | KTF |
|---|---|---|
| Founded | 1974 | 1988 |
| Country | United States | United States |
| Employees | 226 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 399.5M | 361.2M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEO | KTF |
|---|---|---|
| Price | $7.07 | $9.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 92.5K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | ★ 165.16 | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | $1,024.31 | N/A |
| Revenue Next Year | $145.42 | N/A |
| P/E Ratio | ★ N/A | $23.60 |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $4.00 | $8.48 |
| 52 Week High | $7.54 | $9.37 |
Technical Indicators
Market Signals| Indicator | ABEO | KTF |
|---|---|---|
| Relative Strength Index (RSI) | 73.59 | 51.93 |
| Support Level | $4.85 | $9.12 |
| Resistance Level | N/A | $9.27 |
| Average True Range (ATR) | 0.35 | 0.05 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 91.07 | 54.29 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
About KTF DWS Municipal Income Trust
DWS Municipal Income Trust is a closed-ended fixed income mutual fund launched and managed by Deutsche Investment Management Americas, Inc. The company invests in the fixed income markets of the United States. The fund invests in investment-grade tax-exempt municipal securities which are exempt from federal income tax. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index. The Fund invests in various states, such as Texas, Florida, Pennsylvania, Illinois, and California.